Clinical trial
Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and…
NCT00313859 · Samsung Medical Center, Other · Completed
Key facts
| NCT number | NCT00313859 |
|---|---|
| Title | Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC |
| Official title | Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic Colorectal Cancer |
| Lead sponsor | Samsung Medical Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Metastasis |
| Intervention type | Drug |
| Interventions | simvastatin |
| Enrollment | 50 |
| Start date | Sep 1, 2005 |
| Completion | Aug 1, 2007 |
| First posted | Apr 12, 2006 |
| Last update posted | Feb 2, 2012 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: